Croviget Tablet 10/20 Milligrams

Adult dose

This medication is administered once daily regardless of meals. For primary hypercholesterolemia, it is administered in the range of 10/5mg to 10/20mg per day. A starting dose of 10/5mg per day is recommended. For patients requiring more LDL cholesterol reduction, the dose may be adjusted. After initiating treatment or adjusting the dose, lipid levels should be checked at intervals of more than 4 weeks to adjust the dose.

This medication may rarely cause rhabdomyolysis, which can lead to serious muscle damage. Particularly, patients with acute infections, hypotension, major surgery or trauma, serious metabolic and endocrine disorders should temporarily discontinue or stop using this medication. Patients with allergies to the main ingredient or components of this medication, severely impaired liver function, muscle disease, certain renal impairment, pregnant or breastfeeding women should not take this medication. Furthermore, patients at high risk for myopathy, such as those with moderately impaired renal function, hypothyroid patients, family history of muscle disease, alcoholics, and those taking certain concomitant medications should use this medication with caution. This medication may affect liver function, so regular liver function tests should be performed before and during treatment. Symptoms such as muscle pain, weakness, fatigue, fever should be reported to medical personnel immediately, and blood tests may be required to check for muscle damage if necessary. This medication may interact with other drugs, so it is important to inform medical personnel of all medications being taken, especially when combined with anticoagulants, fibrates, certain antibiotics, antifungals, etc. Women who are pregnant or may become pregnant should use an appropriate method of contraception during treatment with this medication, and it should be discontinued immediately if pregnancy is confirmed. Breastfeeding women should also avoid taking this medication. The safety and efficacy of this medication in children and adolescents have not been sufficiently established, so it is not recommended for this age group. Elderly patients or those with impaired renal and hepatic function should be more cautious when taking this medication, and dose adjustment may be necessary. There is no specific antidote for overdose, so treatment should be symptomatic and involve testing for liver function and muscle damage. This medication should be kept out of reach of children and it is advisable not to transfer it to another container. Dizziness or headaches may occur during treatment, so caution should be taken when driving or operating machinery.

Serious side effects

Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, pallor, severe rash accompanied by high fever, blisters, peeling skin, pain in oral/ocular mucosa, breathing difficulties or shortness of breath, asthma attack, respiratory abnormalities coexisting with cough and fever, jaundice (yellowing of the skin or eyes), extreme lethargy, sudden and severe headache, lightning headache, seizures, confusion of consciousness, visual disturbances, paralysis, urination problems

Mild side effects

• Headache
• dizziness
• constipation
• nausea
• abdominal pain
• muscle pain
• swelling
• elevated bilirubin levels in the blood
• acne-like dermatitis
• itching

This medication should be stored in a tightly closed container to prevent exposure to air or moisture. It is recommended to store it at room temperature between 1 and 30 degrees Celsius.

Appearance

White to nearly white round film-coated tablet

Package unit

30 tablets (15 tablets/blister × 2)